Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: Experience from trials of flosequinan

American Heart Journal

Volumn 132, Issue 1 I, 1996, Pages 130-136

  Massie, B M ^a   Shah, N B ^a   Pitt, B ^a   Packer, M ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLOSEQUINAN;

ADULT; AMBULATORY MONITORING; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CHRONOTROPISM; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; ELECTROCARDIOGRAM; EXERCISE; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; STANDING; SUPINE POSITION; TACHYCARDIA;

EID: 0029903962     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90401-9     Document Type: Article

References (0)